Invesco’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-114,863
| Closed | -$39.5K | – | 3824 |
|
|
2025
Q1 | $39.5K | Buy |
114,863
+59,991
| +109% | +$20.6K | ﹤0.01% | 3703 |
|
|
2024
Q4 | $78.5K | Sell |
54,872
-611
| -1% | -$874 | ﹤0.01% | 3636 |
|
|
2024
Q3 | $105K | Buy |
55,483
+10,427
| +23% | +$19.7K | ﹤0.01% | 3599 |
|
|
2024
Q2 | $90.6K | Sell |
45,056
-279,354
| -86% | -$562K | ﹤0.01% | 3750 |
|
|
2024
Q1 | $1.45M | Buy |
324,410
+275,680
| +566% | +$1.24M | ﹤0.01% | 2814 |
|
|
2023
Q4 | $113K | Sell |
48,730
-16,302
| -25% | -$37.8K | ﹤0.01% | 3659 |
|
|
2023
Q3 | $82.6K | Buy |
65,032
+26,416
| +68% | +$33.5K | ﹤0.01% | 3733 |
|
|
2023
Q2 | $127K | Buy |
38,616
+5,805
| +18% | +$19.1K | ﹤0.01% | 3672 |
|
|
2023
Q1 | $135K | Sell |
32,811
-462
| -1% | -$1.9K | ﹤0.01% | 3663 |
|
|
2022
Q4 | $195K | Sell |
33,273
-528,001
| -94% | -$3.09M | ﹤0.01% | 3665 |
|
|
2022
Q3 | $3.8M | Buy |
561,274
+532,084
| +1,823% | +$3.6M | ﹤0.01% | 2352 |
|
|
2022
Q2 | $135K | Sell |
29,190
-878
| -3% | -$4.06K | ﹤0.01% | 3797 |
|
|
2022
Q1 | $120K | Buy |
30,068
+350
| +1% | +$1.4K | ﹤0.01% | 3815 |
|
|
2021
Q4 | $185K | Sell |
29,718
-2,493
| -8% | -$15.5K | ﹤0.01% | 3766 |
|
|
2021
Q3 | $303K | Buy |
32,211
+5,166
| +19% | +$48.6K | ﹤0.01% | 3616 |
|
|
2021
Q2 | $368K | Sell |
27,045
-385,125
| -93% | -$5.24M | ﹤0.01% | 3523 |
|
|
2021
Q1 | $6.67M | Sell |
412,170
-918,419
| -69% | -$14.9M | ﹤0.01% | 2209 |
|
|
2020
Q4 | $35.4M | Buy |
1,330,589
+213,173
| +19% | +$5.67M | 0.01% | 1156 |
|
|
2020
Q3 | $20.8M | Buy |
1,117,416
+134,621
| +14% | +$2.51M | 0.01% | 1284 |
|
|
2020
Q2 | $23M | Buy |
+982,795
| New | +$23M | 0.01% | 1225 |
|